OKYO — OKYO Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $51.24m
- $49.93m
Annual cashflow statement for OKYO Pharma, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.27 | -3.02 | -6.22 | -13.3 | -16.8 |
| Depreciation | |||||
| Non-Cash Items | 0.178 | 0.903 | 1.77 | 1.44 | 4.64 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.13 | 0.859 | -1.02 | 4.14 | 2.67 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -0.961 | -1.24 | -5.47 | -7.7 | -9.49 |
| Capital Expenditures | 0 | -0.005 | -0.002 | -0.006 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.104 | -0.009 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.104 | -0.014 | -0.002 | -0.006 | 0 |
| Financing Cash Flow Items | 0 | 0.001 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.774 | 6.06 | 2.15 | 9.32 | 6.21 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.291 | 4.8 | -3.32 | 1.62 | -3.28 |